Fairvalue-Calculator Fairvalue-Calculator
EN DE

Beijing Wandong Medical Technology Co (600055) Fair Value & Analysis

Healthcare · CN · Market cap 8.1B CNY

Price¥11.27
Fair Value¥2.27
Upside-79.9%
Quality92/100
Evidence: Low Range ¥1.14 – ¥3.44

Analysis

Beijing Wandong Medical Technology Co (600055) currently trades at ¥11.27, while our model-based Fair Value estimate is ¥2.27 — implying the stock looks roughly 79.9% overvalued today. We read business quality at 92/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: low).

About the company

Beijing Wandong Medical Technology Co.,Ltd. engages in the research, development, manufactures, sales, and after-sale services of digital imaging equipment in China. It operates through two segments Medical Equipment Sales Business; and Medical Services and Others. The company provides digital X radiography system (DR), including panorama DR; magnetic resonance imaging system (MRI) for clinical magnetic resonance imaging; X-ray computed tomography system (CT) for clinical X-ray; vascular interventional therapy system (DSA) for clinical examination and interventional treatment of cardiovascular, cerebrovascular, peripheral vascular, and other diseases; flat panel gastrointestinal diagnostic system; digital flat panel breast system; and mobile x-ray machine. The company was formerly known as China Resources Wandong Medical Equipment Co., Ltd. Beijing Wandong Medical Technology Co.,Ltd. company was founded in 1955 and is headquartered in Beijing, China.

Open the full interactive analysis →

Similar stocks

Abbott Laboratories, (ABTT34) -20% Stryker Corporation (S1YK34) -45% Medtronic plc (MDT) -27% Boston Scientific Corporation (B1SX34) -5% Edwards Lifesciences Corporation (EW) -52% Siemens Healthineers AG (SEMHF) +11%

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.